Standardized Follow-up of Patients with Symptomatic Knee Osteoarthritis Treated with a Single Intra-articular Injection of a Combination of Cross-Linked Hyaluronic Acid and Mannitol. - Wikidata - awgldk - TriplyDB

Standardized Follow-up of Patients with Symptomatic Knee Osteoarthritis Treated with a Single Intra-articular Injection of a Combination of Cross-Linked Hyaluronic Acid and Mannitol.

Standardized Follow-up of Patients with Symptomatic Knee Osteoarthritis Treated with a Single Intra-articular Injection of a Combination of Cross-Linked Hyaluronic Acid and Mannitol.

http://www.wikidata.org/entity/Q37283293

about

Predictors of response to viscosupplementation in patients with hip osteoarthritis: results of a prospective, observational, multicentre, open-label, pilot study.Imaging Guidance Improves the Results of Viscosupplementation with HANOX-M-XL in Patients with Ankle Osteoarthritis: Results of a Clinical Survey in 50 Patients Treated in Daily Practice.Getting Better or Getting Well? The Patient Acceptable Symptom State (PASS) Better Predicts Patient's Satisfaction than the Decrease of Pain, in Knee Osteoarthritis Subjects Treated with Viscosupplementation.Evaluation of different commercial hyaluronic acids as a vehicle for injection of human adipose-derived mesenchymal stem cells

P2860

Q36241176-92586E04-AA13-4CC2-8AFC-B752F14609AF Q37432233-2589E115-FA0B-4E3A-81AE-D932A2E9D510 Q38628579-AC92163D-2CD9-4E5D-BAC2-307F1347F951 Q57171240-AFCD4B1A-598C-46E2-9A7D-F3E52542080A

P2860

Standardized Follow-up of Patients with Symptomatic Knee Osteoarthritis Treated with a Single Intra-articular Injection of a Combination of Cross-Linked Hyaluronic Acid and Mannitol.

http://www.wikidata.org/entity/Q37283293

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 25 September 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Standardized Follow-up of Pati ...... Hyaluronic Acid and Mannitol.

@en

Standardized Follow-up of Pati ...... Hyaluronic Acid and Mannitol.

@nl

type

label

Standardized Follow-up of Pati ...... Hyaluronic Acid and Mannitol.

@en

Standardized Follow-up of Pati ...... Hyaluronic Acid and Mannitol.

@nl

prefLabel

Standardized Follow-up of Pati ...... Hyaluronic Acid and Mannitol.

@en

Standardized Follow-up of Pati ...... Hyaluronic Acid and Mannitol.

@nl

P1433

Q37283293-8AFB2A22-ACC3-4BFA-AE36-01A6B6F86753

P1476

Q37283293-F2C00DD2-388B-43DD-B618-E7914FA9088F

P2093

Q37283293-0CEE7BEA-5494-42D5-8D4D-E80AABAF5270

Q37283293-65717A30-0875-429E-B7EE-1E9512493D8C

Q37283293-9314C02B-DD96-418A-AA59-13F4EE88C18E

Q37283293-C7F5ACE6-6BB5-4C20-B76D-DAE041A1650E

Q37283293-D74BF0AD-9B34-4702-BF70-FEB9B63DC970

Q37283293-FBA51784-5EAB-4675-9B07-8AB559BEC61A

P2860

Q37283293-0BC2D6DF-F7D9-4279-9DDB-C87CE5657499

Q37283293-1AFFB6C5-A494-4534-8CB1-2AF0A43EE38B

Q37283293-25CD986B-F6F7-4266-BFBC-E1A2B361E846

Q37283293-2B14DADB-31A4-43A7-8517-1313AAED01F5

Q37283293-3772D02D-F5D0-40E4-AA91-5BA94CB84186

Q37283293-386318B1-A47F-41D7-97D5-6219A4365766

Q37283293-443A1691-5D54-4CE6-AA38-2A4D333C2F84

Q37283293-45FDA36A-301D-4C4D-9684-AB2C7F7342AE

Q37283293-4BAB1155-8480-4E9F-94EA-E480713139BA

Q37283293-5144DC51-27A0-4940-BB8D-03E62611F079

P304

Q37283293-B47D68BF-6B04-4868-9E4B-13E8200D3D9D

P31

Q37283293-7B7DAAA1-04D4-4672-A16A-68106668D538

P356

Q37283293-AEC49D71-2028-4586-A76C-8583145EEC52

P478

Q37283293-54F5B893-94CF-4B1A-865F-DD9B4383A4AF

P577

Q37283293-0793BEFE-34A1-4781-BBB1-581258C50124

P698

Q37283293-BDEE4EF2-98B7-48DF-B6B9-510E6BFF72BB

P921

Q37283293-90DF6FFC-E101-4159-B28C-AF35A782B24D

P932

Q37283293-AFF15C30-E1C8-46A9-A62F-F5FDB8D10E76

P356

P1433

Clinical medicine insights. Arthritis and musculoskeletal disorders

P1476

Standardized Follow-up of Pati ...... Hyaluronic Acid and Mannitol.

@en

P2093

Ana-Maria Bozgan

http://www.w3.org/2001/XMLSchema#string

Anne Lohse-Walliser

http://www.w3.org/2001/XMLSchema#string

Jean-Charles Balblanc

http://www.w3.org/2001/XMLSchema#string

Marie Bossert

http://www.w3.org/2001/XMLSchema#string

Maxime Sondag

http://www.w3.org/2001/XMLSchema#string

Thierry Conrozier

http://www.w3.org/2001/XMLSchema#string

P2860

EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)

A consensus statement on the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) algorithm for the management of knee osteoarthritis-From evidence-based medicine to the real-life setting

Viscosupplementation for Osteoarthritis of the Knee

Radiological assessment of osteo-arthrosis

Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee

American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee.

Guidance on the management of pain in older people.

OARSI guidelines for the non-surgical management of knee osteoarthritis.

Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysis.

Patient preference and willingness to pay for knee osteoarthritis treatments

P304

175-179

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4137/CMAMD.S39432

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27688712

http://www.w3.org/2001/XMLSchema#string

P921

P932

5036533

http://www.w3.org/2001/XMLSchema#string